<VariationArchive VariationID="42049" VariationName="NM_000227.6(LAMA3):c.151dup (p.Val51fs)" VariationType="Duplication" Accession="VCV000042049" Version="12" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-10" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="51215" VariationID="42049">
      <GeneList>
        <Gene Symbol="LAMA3" FullName="laminin subunit alpha 3" GeneID="3909" HGNC_ID="HGNC:6483" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>18q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="23689453" stop="23955066" display_start="23689453" display_stop="23955066" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="21269561" stop="21535029" display_start="21269561" display_stop="21535029" Strand="+" />
          </Location>
          <OMIM>600805</OMIM>
        </Gene>
        <Gene Symbol="LOC126862707" FullName="MED14-independent group 3 enhancer GRCh37_chr18:21452354-21453553" GeneID="126862707" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>18q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="23872390" stop="23873589" display_start="23872390" display_stop="23873589" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000227.6(LAMA3):c.151dup (p.Val51fs)</Name>
      <CanonicalSPDI>NC_000018.10:23873194:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>18q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="23873194" stop="23873195" display_start="23873194" display_stop="23873195" variantLength="1" positionVCF="23873194" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="21453158" stop="21453159" display_start="21453158" display_stop="21453159" variantLength="1" positionVCF="21453158" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>V51fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.23873195dup" Assembly="GRCh38">
            <Expression>NC_000018.10:g.23873195dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.21453159dup" Assembly="GRCh37">
            <Expression>NC_000018.9:g.21453159dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007853.2" sequenceAccession="NG_007853" sequenceVersion="2" change="g.188598dup">
            <Expression>NG_007853.2:g.188598dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000227.6" sequenceAccession="NM_000227" sequenceVersion="6" change="c.151dup" MANEPlusClinical="true">
            <Expression>NM_000227.6:c.151dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000218.3" sequenceAccession="NP_000218" sequenceVersion="3" change="p.Val51fs">
            <Expression>NP_000218.3:p.Val51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127718.4" sequenceAccession="NM_001127718" sequenceVersion="4" change="c.151dup">
            <Expression>NM_001127718.4:c.151dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121190.2" sequenceAccession="NP_001121190" sequenceVersion="2" change="p.Val51fs">
            <Expression>NP_001121190.2:p.Val51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198129.4" sequenceAccession="NM_198129" sequenceVersion="4" change="c.4998+1534dup" MANESelect="true">
            <Expression>NM_198129.4:c.4998+1534dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127717.4" sequenceAccession="NM_001127717" sequenceVersion="4" change="c.4998+1534dup">
            <Expression>NM_001127717.4:c.4998+1534dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000227.4" sequenceAccession="NM_000227" sequenceVersion="4" change="c.151dupG">
            <Expression>NM_000227.4:c.151dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA341810" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600805.0004" DB="OMIM" />
        <XRef Type="rs" ID="80356678" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000227.6(LAMA3):c.151dup (p.Val51fs) AND Laryngo-onycho-cutaneous syndrome" Accession="RCV000009339" Version="6">
        <ClassifiedConditionList TraitSetID="2423">
          <ClassifiedCondition DB="MedGen" ID="C1328355">Laryngo-onycho-cutaneous syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000227.6(LAMA3):c.151dup (p.Val51fs) AND Junctional epidermolysis bullosa gravis of Herlitz" Accession="RCV000020425" Version="3">
        <ClassifiedConditionList TraitSetID="2421">
          <ClassifiedCondition DB="MedGen" ID="C0079683">Junctional epidermolysis bullosa gravis of Herlitz</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-02-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000227.6(LAMA3):c.151dup (p.Val51fs) AND not provided" Accession="RCV001852701" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-23" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10366601</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11810295</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12915477</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17362460</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22434185</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23869449</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27827380</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28087116</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301304</ID>
          <ID Source="BookShelf">NBK1125</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2421" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5022" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, Herlitz-Pearson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-Pearson type epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Letalis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa gravis of Herlitz</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Letalis/2580" DB="Genetic Alliance" />
                <XRef ID="400140006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JEB-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-type junctional epidermolysis bullosa</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2153" />
                <XRef ID="2153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <XRef ID="79404" DB="Orphanet" />
              <XRef ID="C0079683" DB="MedGen" />
              <XRef ID="MONDO:0009182" DB="MONDO" />
              <XRef Type="MIM" ID="226700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2423" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2539" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Logic syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Laryngo-onycho-cutaneous syndrome</ElementValue>
                <XRef ID="MONDO:0009513" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS</ElementValue>
                <XRef Type="MIM" ID="245660" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600805.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600805.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600805.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600805.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600805.0009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Laryngoonychocutaneous syndrome</ElementValue>
                <XRef ID="Laryngoonychocutaneous+syndrome/4105" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JEB2C</ElementValue>
                <XRef Type="MIM" ID="245660" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="368" />
                <XRef ID="368" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2407" DB="Orphanet" />
              <XRef ID="C1328355" DB="MedGen" />
              <XRef ID="MONDO:0009513" DB="MONDO" />
              <XRef Type="MIM" ID="245660" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="40829" SubmissionDate="2013-04-30" DateLastUpdated="2013-05-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="AY327114.1:c.151insG_NBK1125" title="AY327114.1:c.151insG and Junctional Epidermolysis Bullosa" />
        <ClinVarAccession Accession="SCV000040829" DateUpdated="2013-05-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-02-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">AY327114.1:c.151insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Junctional Epidermolysis Bullosa</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1125" />
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4233497" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4947761|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002216726" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12915477</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10366601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11810295</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12915477</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17362460</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22434185</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23869449</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27827380</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28087116</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 42049). This premature translational stop signal has been observed in individual(s) with laryngoonychocutaneous syndrome (PMID: 12915477). This variant is present in population databases (rs763733524, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Val51Glyfs*4) in the LAMA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA3 are known to be pathogenic (PMID: 10366601, 11810295, 12915477, 16473856, 17362460, 22434185, 23869449, 27827380, 28087116).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.21453158_21453159insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="29557" SubmissionDate="2022-03-29" DateLastUpdated="2022-04-02" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600805.0004_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS" title="LAMA3, 1-BP INS, 151G_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS" />
        <ClinVarAccession Accession="SCV000029557" DateUpdated="2022-04-02" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-09-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of 15 consanguineous Punjabi families with laryngoonychocutaneous syndrome (JEB2C; 245660), McLean et al. (2003) identified a 1-bp insertion (151insG) in the LAMA3 gene that caused a frameshift and a predicted stop codon in an exon that is specific to the laminin alpha-3a isoform. The mutation did not result in nonsense-mediated mRNA decay due to rescue of the transcript by an alternative translation start site 6 exons downstream. The resultant N-terminal deletion of laminin alpha-3a was confirmed by immunoprecipitation of secreted proteins from LOC keratinocytes.</Attribute>
              <Citation>
                <ID Source="PubMed">12915477</ID>
              </Citation>
              <XRef DB="OMIM" ID="245660" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA3" />
          </GeneList>
          <Name>LAMA3, 1-BP INS, 151G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 151G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600805.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4538530" SubmissionDate="2022-03-25" DateLastUpdated="2022-04-02" DateCreated="2022-04-02">
        <ClinVarSubmissionID localKey="18-21453158-T-TG" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002318758" DateUpdated="2022-04-02" DateCreated="2022-04-02" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12915477</ID>
          </Citation>
          <Comment>The variant has been observed in multiple (&gt;3) similarly affected unrelated individuals (PMID: 12915477). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000042049, PMID:12915477, 3billion dataset). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency:0.0000159). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000988" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001805" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198129.4:c.4998+1534dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="245660" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11208158</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2670206" SubmissionDate="2022-07-15" DateLastUpdated="2022-07-17" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000227.4:c.151dupG|MedGen:C1328355" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001361867" DateUpdated="2022-07-17" DateCreated="2020-06-22" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12915477</ID>
          </Citation>
          <Comment>Variant summary: LAMA3 c.151dupG (p.Val51GlyfsX4) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2e-05 in 251694 control chromosomes (gnomAD and publication data), exclusively reported within the South Asian subpopulation, where it has been described as a founder mutation confined to the Punjabi population (McLean_2003). The variant, c.151dupG, has been reported in the literature in several homozygous, and at least one compound heterozygous individual affected with Laryngoonychocutaneous (or Shabbir) syndrome (McLean_2003). These data indicate that the variant is very likely to be associated with disease. This publication also reported experimental evidence evaluating an impact on protein function, and demonstrated that the variant caused a frameshift with a predicted stop codon in an exon that is specific to the laminin alpha-3a isoform, however did not result in nonsense-mediated mRNA decay due to rescue of the transcript by an alternative translation start site downstream, thus resulting in an N-terminal truncation of the laminin alpha-3a protein. The altered protein was demonstrated to be present in normal amount in patient derived skin biopsy material, however decreased cell-stromal junctions with reduced numbers of anchoring filaments were detected that is consistent with mechanism of the disease (McLean_2003). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000227.4:c.151dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1328355" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11800792</SubmissionName>
          <SubmissionName>SUB6913290</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4538530" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000988" MappingRef="HP">
        <MedGen CUI="C5779628" Name="Skin rash" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538530" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001805" MappingRef="HP">
        <MedGen CUI="C0263537" Name="Onychogryposis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538530" TraitType="Disease" MappingType="XRef" MappingValue="245660" MappingRef="OMIM">
        <MedGen CUI="C1328355" Name="Laryngo-onycho-cutaneous syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="40829" TraitType="Disease" MappingType="Name" MappingValue="Junctional Epidermolysis Bullosa" MappingRef="Preferred">
        <MedGen CUI="C0079301" Name="Junctional epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4233497" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2670206" TraitType="Disease" MappingType="XRef" MappingValue="C1328355" MappingRef="MedGen">
        <MedGen CUI="C1328355" Name="Laryngo-onycho-cutaneous syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="29557" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA, JUNCTIONAL 2C, LARYNGOONYCHOCUTANEOUS" MappingRef="Preferred">
        <MedGen CUI="C1328355" Name="Laryngo-onycho-cutaneous syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

